Histone citrullination: a new target for tumors.

Molecular Cancer
Dongwei ZhuShengjun Wang

Abstract

As the main protein components of chromatin, histones play central roles in gene regulation as spools of winding DNA. Histones are subject to various modifications, including phosphorylation, acetylation, glycosylation, methylation, ubiquitination and citrullination, which affect gene transcription. Histone citrullination, a posttranscriptional modification catalyzed by peptidyl arginine deiminase (PAD) enzymes, is involved in human carcinogenesis. In this study, we highlighted the functions of histone citrullination in physiological regulation and tumors. Additionally, because histone citrullination involves forming neutrophil extracellular traps (NETs), the relationship between NETs and tumors was illustrated. Finally, the clinical application of histone citrullination and PAD inhibitors was discussed.

References

Feb 1, 1981·Scientific American·R D Kornberg, A Klug
Jan 1, 1981·Journal of Biochemistry·M Fujisaki, K Sugawara
Sep 1, 1993·Journal of Neurochemistry·J W Lamensa, M A Moscarello
Mar 17, 1998·Biochemical and Biophysical Research Communications·H AsagaT Senshu
Mar 25, 2000·The Journal of Investigative Dermatology·A Ishida-YamamotoH Iizuka
Jun 7, 2000·Proceedings of the National Academy of Sciences of the United States of America·K YodaT Okazaki
Nov 30, 2000·Arthritis Research·W J van Venrooij, G J Pruijn
Jan 19, 2002·Biochemical and Biophysical Research Communications·Teruki HagiwaraMichiyuki Yamada
Mar 7, 2002·Arthritis Research·Martinus A M van BoekelWalther J van Venrooij
Oct 24, 2002·Archives of Biochemistry and Biophysics·Akihito IshigamiNaoki Maruyama
Oct 24, 2002·The Journal of Biological Chemistry·Katsuhiko NakashimaMichiyuki Yamada
Oct 28, 2003·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Erik R VossenaarGer J M Pruijn
Dec 4, 2003·Acta Crystallographica. Section D, Biological Crystallography·Kyouhei AritaMamoru Sato
Mar 6, 2004·Science·Volker BrinkmannArturo Zychlinsky
Mar 17, 2004·Annals of the Rheumatic Diseases·E R VossenaarW J van Venrooij
Jul 13, 2004·Nature Structural & Molecular Biology·Kyouhei AritaMamoru Sato
Sep 2, 2004·Cell·Graeme L CuthbertTony Kouzarides
Jan 29, 2005·The Journal of Investigative Dermatology·Rachida NachatMichel Simon
Feb 26, 2005·Proceedings of the National Academy of Sciences of the United States of America·Young-Ho LeeMichael R Stallcup
Feb 8, 2006·Nature Structural & Molecular Biology·David T BrownTom Misteli
Aug 22, 2006·Experimental and Molecular Pathology·Sally A DuPre', Kenneth W Hunter
Sep 16, 2006·Journal of Dermatological Science·Stéphane ChavanasMichel Simon
Nov 3, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Fabrizio G MastronardiMario A Moscarello
Jan 11, 2007·The Journal of Cell Biology·Tobias A FuchsArturo Zychlinsky
Feb 17, 2007·Journal of Molecular Biology·Reinout RaijmakersGer J M Pruijn
Apr 27, 2007·Annals of the New York Academy of Sciences·Kalliope E Sekeri-Pataryas, Thomae G Sourlingas
May 21, 2008·International Journal of Cosmetic Science·M-C MéchinM Simon
May 24, 2008·The Journal of Biological Chemistry·Hongjie YaoYanming Wang
May 29, 2008·Molecular and Cellular Biology·Pingxin LiYanming Wang
Sep 6, 2008·Nucleic Acids Research·Andrea KinnerGeorge Iliakis

❮ Previous
Next ❯

Citations

Sep 3, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Zehui TanXin Zhai

❮ Previous
Next ❯

Software Mentioned

CitrSite
CKSAAP

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.